Top stories of 2012 in cardiology

To help identify trends and find out what DAIC readers are interested in, the magazine takes note of what they click on when visiting the website. Below are the top 25 stories from 2012, and the top 10 stories read in 2012 that were written in previous years.

An estimated 17 million people throughout the world die annually of cardiovascular diseases, specifically heart attacks or strokes. Time is a critical factor in diagnosing and treating people who may be having a potential heart attack. To aid physicians in detecting heart attacks sooner, Abbott announced CE marking for the Architect Stat High Sensitive Troponin-I Assay.

MRI, CT Systems Imaging Transparent Pricing Study

In a study designed to see if doctors who are told the exact price of expensive medical tests like magnetic resonance imaging (MRI) in advance would order fewer of them, Johns Hopkins researchers got their answer: No.
Millennium Research Group Peripheral Vascular Device Market Growth

According to Millennium Research Group (MRG), increasing awareness and diagnosis of peripheral vascular disease (PVD) along with the introduction of improved next-generation devices will lead the United States peripheral vascular (PV) device market to grow strongly to reach $3.3 billion by 2017.

AngioScore Inc. announced the launch of its new 100 mm length AngioSculpt PTA Scoring Balloon Catheters for the treatment of peripheral artery disease (PAD) below the knee (BTK).

Fujifilm Medical Systems U.S.A. Inc. brought a broad portfolio of diagnostic and informatic solutions to the 2012 meeting of the Radiological Society of North America (RSNA). The company showcased its advanced Cardiovascular product, Synapse Cardiovascular 5.0.

 

January 25, 2013 — Mobile drug reference app provider Epocrates recently conducted its annual survey of cardiologists to uncover the biggest trends and challenges facing them today. The survey explores their perspectives on a range of issues related to patient care, healthcare technology usage/adoption and practice concerns. Following are some highlights from the survey findings.

The American College of Cardiology (ACC) has released the late-breaking clinical trials that will be highlighted as the cutting edge of cardiology at the ACC.13 annual meeting March 9-11 in San Francisco. 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now